MMPs can lead to the shedding of CD44 from the cell surface [112], while soluble CD44 antagonizes CD44-mediated cellular binding to HA and can modulate or inhibit tumor development [113] and tumor cell migration [114]. This evidence concerns the gene CD44 and neoplasm.